Cingulate Net Worth

Cingulate Net Worth Breakdown

  CING
The net worth of Cingulate is the difference between its total assets and liabilities. Cingulate's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Cingulate's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Cingulate's net worth can be used as a measure of its financial health and stability which can help investors to decide if Cingulate is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Cingulate stock.

Cingulate Net Worth Analysis

Cingulate's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Cingulate's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Cingulate's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Cingulate's net worth analysis. One common approach is to calculate Cingulate's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Cingulate's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Cingulate's net worth. This approach calculates the present value of Cingulate's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Cingulate's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Cingulate's net worth. This involves comparing Cingulate's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Cingulate's net worth relative to its peers.
To determine if Cingulate is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Cingulate's net worth research are outlined below:
Cingulate had very high historical volatility over the last 90 days
Cingulate has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (15.55 M) with loss before overhead, payroll, taxes, and interest of (9.86 M).
Cingulate currently holds about 8.2 M in cash with (18.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.73.
Latest headline from news.google.com: What analysts say about Cingulate Inc. stock - Tremendous portfolio expansion - Autocar Professional
Cingulate uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Cingulate. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Cingulate's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
8th of March 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
8th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Know Cingulate's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Cingulate is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cingulate backward and forwards among themselves. Cingulate's institutional investor refers to the entity that pools money to purchase Cingulate's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Citigroup Inc2025-03-31
0.0
Headlands Technologies Llc2024-12-31
0.0
Commonwealth Equity Services Inc2025-03-31
55.5 K
Geode Capital Management, Llc2025-03-31
30.4 K
Ubs Group Ag2025-03-31
22.1 K
Vanguard Group Inc2025-03-31
10.8 K
Alphamark Advisors, Llc2024-12-31
K
Bank Of America Corp2025-03-31
K
Tower Research Capital Llc2025-03-31
433
Sbi Securities Co Ltd2025-03-31
362
Advisor Group Holdings, Inc.2025-03-31
42.0
Note, although Cingulate's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Cingulate's market capitalization trends

The company currently falls under 'Micro-Cap' category with a current market capitalization of 22.8 M.

Market Cap

15.03 Million

Project Cingulate's profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(1.05)(1.10)
Return On Capital Employed(1.58)(1.66)
Return On Assets(1.05)(1.10)
Return On Equity(2.09)(2.19)
When accessing Cingulate's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Cingulate's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Cingulate's profitability and make more informed investment decisions.

Evaluate Cingulate's management efficiency

Cingulate has return on total asset (ROA) of (1.1414) % which means that it has lost $1.1414 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.5806) %, meaning that it created substantial loss on money invested by shareholders. Cingulate's management efficiency ratios could be used to measure how well Cingulate manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -1.1. The current Return On Capital Employed is estimated to decrease to -1.66. At this time, Cingulate's Non Current Assets Total are most likely to decrease significantly in the upcoming years. The Cingulate's current Non Currrent Assets Other is estimated to increase to about 18.3 B, while Total Assets are projected to decrease to roughly 11.7 M.
Last ReportedProjected for Next Year
Book Value Per Share 1.96  3.26 
Tangible Book Value Per Share 1.96  3.26 
Enterprise Value Over EBITDA(0.75)(0.78)
Price Book Value Ratio 2.52  2.39 
Enterprise Value Multiple(0.75)(0.78)
Price Fair Value 2.52  2.39 
Enterprise Value10.5 M9.3 M
Leadership effectiveness at Cingulate is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Return On Equity
(3.58)
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cingulate insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cingulate's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cingulate insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Cingulate Corporate Filings

8K
25th of July 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F3
10th of July 2025
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
F4
9th of July 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
28th of April 2025
Other Reports
ViewVerify
Cingulate time-series forecasting models is one of many Cingulate's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cingulate's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Cingulate Earnings per Share Projection vs Actual

Cingulate Corporate Executives

Elected by the shareholders, the Cingulate's board of directors comprises two types of representatives: Cingulate inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cingulate. The board's role is to monitor Cingulate's management team and ensure that shareholders' interests are well served. Cingulate's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cingulate's outside directors are responsible for providing unbiased perspectives on the board's policies.
Raul MDExecutive CoFounderProfile
Matthew MDExecutive CoFounderProfile
Jennifer CPASenior CFOProfile
Dr MBAExecutive COOProfile
When determining whether Cingulate is a strong investment it is important to analyze Cingulate's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cingulate's future performance. For an informed investment choice regarding Cingulate Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cingulate. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cingulate. If investors know Cingulate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cingulate listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.03)
Return On Assets
(1.14)
Return On Equity
(3.58)
The market value of Cingulate is measured differently than its book value, which is the value of Cingulate that is recorded on the company's balance sheet. Investors also form their own opinion of Cingulate's value that differs from its market value or its book value, called intrinsic value, which is Cingulate's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cingulate's market value can be influenced by many factors that don't directly affect Cingulate's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cingulate's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cingulate is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cingulate's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.